US 9181206
Dual-acting oxazole antihypertensive agents
granted A61KA61K31/421A61K31/422
Quick answer
US patent 9181206 (Dual-acting oxazole antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/421, A61K31/422, A61K31/4245, A61K31/4439